NOTV · Inotiv, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $513.02M | $490.74M | $572.42M | $547.66M | $89.61M | $60.47M |
| Cost of Revenue | - | - | - | - | $59.45M | $42.23M |
| Gross Profit | - | - | - | - | $30.16M | $18.24M |
| R&D | - | - | - | - | $405.0K | $950.0K |
| SG&A | $71.10M | $77.03M | $108.23M | $82.44M | $30.38M | $16.98M |
| Total Operating Expenses | - | - | - | - | $35.77M | $21.30M |
| D&A | $55.93M | $57.12M | $54.72M | $49.32M | $4.07M | $3.93M |
| Operating Income | ($30.90M) | ($86.41M) | ($81.46M) | ($263.45M) | ($5.62M) | ($3.06M) |
| Interest Expense | $4.28M | $46.88M | $43.02M | $29.70M | $1.68M | $1.49M |
| Income Tax | ($19.14M) | ($21.88M) | ($19.34M) | ($15.19M) | ($4.78M) | $147.0K |
| Net Income | ($68.63M) | ($108.44M) | ($105.14M) | ($337.02M) | $10.89M | ($4.68M) |
| EPS - Basic | ($2.11) | ($4.19) | ($4.10) | ($13.84) | $0.83 | ($0.43) |
| EPS - Diluted | ($2.11) | ($4.19) | ($4.10) | ($13.84) | $0.19 | ($0.43) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $21.74M | $21.43M | $35.49M | $18.52M | $138.92M | $1.41M |
| Accounts Receivable | - | - | - | $88.87M | $20.73M | $8.68M |
| Inventory | $45.74M | $18.17M | $56.10M | $71.44M | $602.0K | $700.0K |
| Accounts Payable | $48.53M | $33.53M | $32.56M | $28.70M | $6.16M | $3.20M |
| Current Assets | $194.59M | $163.41M | $213.80M | $232.98M | $189.02M | $15.30M |
| Total Assets | $771.11M | $781.36M | $856.53M | $962.90M | $321.86M | $61.59M |
| Current Liabilities | $556.78M | $119.04M | $132.19M | $164.10M | $55.11M | $31.64M |
| Long-term Debt | $0 | $389.80M | $369.80M | $330.68M | $154.21M | $18.83M |
| Total Liabilities | $635.09M | $610.86M | $588.04M | $603.13M | $216.73M | $54.00M |
| Stockholders' Equity | $136.03M | $170.50M | $269.15M | $360.37M | $105.13M | $7.60M |
| Retained Earnings | ($630.81M) | ($562.16M) | ($453.28M) | ($348.28M) | ($11.02M) | ($21.91M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($10.46M) | ($6.80M) | $27.88M | ($5.22M) | $10.75M | $1.29M |
| Investing Cash Flow | ($12.89M) | ($16.83M) | ($28.75M) | ($333.72M) | ($54.06M) | ($10.13M) |
| Financing Cash Flow | $23.70M | $9.68M | $15.87M | $203.15M | $198.83M | $9.64M |
| CapEx | $16.61M | $22.31M | $27.50M | $36.30M | $12.47M | $6.20M |
| Free Cash Flow | ($27.07M) | ($29.11M) | $380.0K | ($41.52M) | ($1.73M) | ($4.91M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | 33.7% | 30.2% |
| Operating margin | -6.0% | -17.6% | -14.2% | -48.1% | -6.3% | -5.1% |
| EBITDA margin | 4.9% | -6.0% | -4.7% | -39.1% | -1.7% | 1.4% |
| Net margin | -13.4% | -22.1% | -18.4% | -61.5% | 12.2% | -7.7% |
| Free cash flow margin | -5.3% | -5.9% | 0.1% | -7.6% | -1.9% | -8.1% |
| FCF / Net income | 0.39 | 0.27 | -0.00 | 0.12 | -0.16 | 1.05 |
| R&D / Revenue | - | - | - | - | 0.5% | 1.6% |
| SG&A / Revenue | 13.9% | 15.7% | 18.9% | 15.1% | 33.9% | 28.1% |
| Effective tax rate | - | - | - | - | -78.1% | - |
| Return on assets | -8.9% | -13.9% | -12.3% | -35.0% | 3.4% | -7.6% |
| Return on equity | -50.4% | -63.6% | -39.1% | -93.5% | 10.4% | -61.7% |
| Return on invested capital | -17.9% | -12.2% | -10.1% | -30.1% | -2.2% | -9.2% |
| Liquidity | ||||||
| Current ratio | 0.35 | 1.37 | 1.62 | 1.42 | 3.43 | 0.48 |
| Quick ratio | 0.27 | 1.22 | 1.19 | 0.98 | 3.42 | 0.46 |
| Cash ratio | 0.04 | 0.18 | 0.27 | 0.11 | 2.52 | 0.04 |
| Leverage | ||||||
| Debt / Equity | 0.00 | 2.29 | 1.37 | 0.92 | 1.47 | 2.48 |
| Debt / Assets | 0.00 | 0.50 | 0.43 | 0.34 | 0.48 | 0.31 |
| Debt / EBITDA | 0.00 | - | - | - | - | 21.74 |
| Interest coverage | -7.2x | -1.8x | -1.9x | -8.9x | -3.3x | -2.1x |
| Equity multiplier | 5.67 | 4.58 | 3.18 | 2.67 | 3.06 | 8.11 |
| Liabilities / Assets | 0.82 | 0.78 | 0.69 | 0.63 | 0.67 | 0.88 |
| Efficiency | ||||||
| Asset turnover | 0.67 | 0.63 | 0.67 | 0.57 | 0.28 | 0.98 |
| Inventory turnover | - | - | - | - | 98.75 | 60.33 |
| Days sales outstanding | - | - | - | 59d | 84d | 52d |
| Days inventory outstanding | - | - | - | - | 4d | 6d |
| Days payable outstanding | - | - | - | - | 38d | 28d |
| Cash conversion cycle | - | - | - | - | 50d | 31d |
| Valuation | ||||||
| P / E | - | - | - | - | 153.9x | - |
| P / B | 0.3x | 0.3x | 0.3x | 1.1x | 3.9x | 6.8x |
| P / S | 0.1x | 0.1x | 0.1x | 0.7x | 4.5x | 0.9x |
| EV / EBITDA | 1.0x | - | - | - | - | 80.0x |
| Growth | ||||||
| Revenue growth (YoY) | 4.5% | -14.3% | 4.5% | 511.2% | 48.2% | 38.6% |
| Revenue CAGR (3y) | -2.2% | 76.3% | 111.5% | 132.4% | 50.4% | 35.6% |
| Revenue CAGR (5y) | 53.4% | 62.3% | 85.1% | 86.5% | 34.4% | 21.6% |
| Gross profit growth (YoY) | - | - | - | - | 65.4% | 41.1% |
| Operating income growth (YoY) | 64.2% | -6.1% | 69.1% | -4589.4% | -83.4% | -1902.0% |
| Net income growth (YoY) | 36.7% | -3.1% | 68.8% | - | - | -493.0% |
| EPS growth (YoY) | 49.6% | -2.2% | 70.4% | - | - | -437.5% |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 7.0% | - | - | -2305.4% | 64.8% | 3.7% |
| FCF CAGR (5y) | - | - | -29.4% | - | - | - |
| Book value growth (YoY) | -20.2% | -36.7% | -25.3% | 242.8% | 1284.0% | -29.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-09-30.
Business segments
$513.02M totalResearch Models And Services Segment$325.08M · 63.4%
Discovery And Safety Assessment Segment$187.94M · 36.6%
Product / service
$513.02M totalProduct$280.16M · 54.6%
Service$232.87M · 45.4%
Geographic
$513.02M totalUS$447.98M · 87.3%
NL$35.48M · 6.9%
Other Than United States And Netherlands$29.56M · 5.8%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
-0.40
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✗Net income positive
- ✗Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Commercial Physical & Biological Research
Comparing Inotiv against the 5 most active filers in the same SIC group.